ORGANOGENESIS HOLDINGS INC (ORGO) Fundamental Analysis & Valuation

NASDAQ:ORGO • US68621F1021

Current stock price

2.33 USD
-0.08 (-3.32%)
At close:
2.34 USD
+0.01 (+0.43%)
After Hours:

This ORGO fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. ORGO Profitability Analysis

1.1 Basic Checks

  • In the past year ORGO was profitable.
  • In the past year ORGO has reported a negative cash flow from operations.
  • Of the past 5 years ORGO 4 years were profitable.
  • Of the past 5 years ORGO 4 years had a positive operating cash flow.
ORGO Yearly Net Income VS EBIT VS OCF VS FCFORGO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M

1.2 Ratios

  • ORGO has a Return On Assets of 2.65%. This is amongst the best in the industry. ORGO outperforms 88.95% of its industry peers.
  • ORGO has a better Return On Equity (3.65%) than 90.12% of its industry peers.
  • The Return On Invested Capital of ORGO (8.83%) is better than 92.25% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for ORGO is significantly below the industry average of 27.75%.
  • The last Return On Invested Capital (8.83%) for ORGO is above the 3 year average (5.16%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.65%
ROE 3.65%
ROIC 8.83%
ROA(3y)1.41%
ROA(5y)5.82%
ROE(3y)2.05%
ROE(5y)10.24%
ROIC(3y)5.16%
ROIC(5y)7.22%
ORGO Yearly ROA, ROE, ROICORGO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50 -100

1.3 Margins

  • With an excellent Profit Margin value of 2.81%, ORGO belongs to the best of the industry, outperforming 88.76% of the companies in the same industry.
  • ORGO's Profit Margin has declined in the last couple of years.
  • The Operating Margin of ORGO (9.90%) is better than 90.31% of its industry peers.
  • ORGO's Operating Margin has improved in the last couple of years.
  • ORGO has a better Gross Margin (75.62%) than 82.75% of its industry peers.
  • In the last couple of years the Gross Margin of ORGO has remained more or less at the same level.
Industry RankSector Rank
OM 9.9%
PM (TTM) 2.81%
GM 75.62%
OM growth 3Y26.04%
OM growth 5Y4.64%
PM growth 3Y1.07%
PM growth 5Y-6.94%
GM growth 3Y-0.48%
GM growth 5Y0.38%
ORGO Yearly Profit, Operating, Gross MarginsORGO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. ORGO Health Analysis

2.1 Basic Checks

  • ORGO has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • ORGO has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, ORGO has less shares outstanding
  • Compared to 1 year ago, ORGO has a worse debt to assets ratio.
ORGO Yearly Shares OutstandingORGO Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
ORGO Yearly Total Debt VS Total AssetsORGO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

2.2 Solvency

  • ORGO has an Altman-Z score of 2.90. This is not the best score and indicates that ORGO is in the grey zone with still only limited risk for bankruptcy at the moment.
  • ORGO has a better Altman-Z score (2.90) than 67.44% of its industry peers.
  • ORGO has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of ORGO (0.03) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z 2.9
ROIC/WACC0.93
WACC9.49%
ORGO Yearly LT Debt VS Equity VS FCFORGO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M

2.3 Liquidity

  • A Current Ratio of 3.62 indicates that ORGO has no problem at all paying its short term obligations.
  • With a Current ratio value of 3.62, ORGO perfoms like the industry average, outperforming 43.99% of the companies in the same industry.
  • A Quick Ratio of 3.32 indicates that ORGO has no problem at all paying its short term obligations.
  • Looking at the Quick ratio, with a value of 3.32, ORGO is in line with its industry, outperforming 42.64% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.62
Quick Ratio 3.32
ORGO Yearly Current Assets VS Current LiabilitesORGO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. ORGO Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 52.94% over the past year.
  • Measured over the past years, ORGO shows a quite strong growth in Earnings Per Share. The EPS has been growing by 16.72% on average per year.
  • The Revenue has grown by 17.04% in the past year. This is quite good.
  • ORGO shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.77% yearly.
EPS 1Y (TTM)52.94%
EPS 3Y25.99%
EPS 5Y16.72%
EPS Q2Q%416.67%
Revenue 1Y (TTM)17.04%
Revenue growth 3Y7.76%
Revenue growth 5Y10.77%
Sales Q2Q%78.13%

3.2 Future

  • Based on estimates for the next years, ORGO will show a decrease in Earnings Per Share. The EPS will decrease by -5.01% on average per year.
  • Based on estimates for the next years, ORGO will show a decrease in Revenue. The Revenue will decrease by -0.44% on average per year.
EPS Next Y-166.69%
EPS Next 2Y-5.01%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-21.5%
Revenue Next 2Y-0.44%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ORGO Yearly Revenue VS EstimatesORGO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
ORGO Yearly EPS VS EstimatesORGO Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4 -0.4 0.6

More info and screens

Find the best growth stocksShow best growing peers

4

4. ORGO Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 8.96, which indicates a very decent valuation of ORGO.
  • Based on the Price/Earnings ratio, ORGO is valued cheaper than 96.90% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of ORGO to the average of the S&P500 Index (27.47), we can say ORGO is valued rather cheaply.
  • The Forward Price/Earnings Ratio is negative for ORGO. No positive earnings are expected for the next year.
Industry RankSector Rank
PE 8.96
Fwd PE N/A
ORGO Price Earnings VS Forward Price EarningsORGO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ORGO is valued cheaply inside the industry as 98.64% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 3.2
ORGO Per share dataORGO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

  • The decent profitability rating of ORGO may justify a higher PE ratio.
  • A cheap valuation may be justified as ORGO's earnings are expected to decrease with -5.01% in the coming years.
PEG (NY)N/A
PEG (5Y)0.54
EPS Next 2Y-5.01%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ORGO Dividend Analysis

5.1 Amount

  • ORGO does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ORGO Fundamentals: All Metrics, Ratios and Statistics

ORGANOGENESIS HOLDINGS INC

NASDAQ:ORGO (4/23/2026, 8:00:02 PM)

After market: 2.34 +0.01 (+0.43%)

2.33

-0.08 (-3.32%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-26
Earnings (Next)05-07
Inst Owners54.55%
Inst Owner Change0.4%
Ins Owners32.5%
Ins Owner Change1.24%
Market Cap299.73M
Revenue(TTM)564.17M
Net Income(TTM)15.85M
Analysts85.71
Price Target8.16 (250.21%)
Short Float %18.99%
Short Ratio10.48
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)106.05%
Min EPS beat(2)44.72%
Max EPS beat(2)167.38%
EPS beat(4)2
Avg EPS beat(4)16.53%
Min EPS beat(4)-73%
Max EPS beat(4)167.38%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)19.19%
Min Revenue beat(2)10.3%
Max Revenue beat(2)28.08%
Revenue beat(4)2
Avg Revenue beat(4)6.94%
Min Revenue beat(4)-6.36%
Max Revenue beat(4)28.08%
Revenue beat(8)6
Avg Revenue beat(8)7.04%
Revenue beat(12)7
Avg Revenue beat(12)4.32%
Revenue beat(16)7
Avg Revenue beat(16)2.3%
PT rev (1m)-5.88%
PT rev (3m)-5.88%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-244.44%
EPS NY rev (1m)-580%
EPS NY rev (3m)-217.24%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-56.57%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-26.17%
Valuation
Industry RankSector Rank
PE 8.96
Fwd PE N/A
P/S 0.53
P/FCF N/A
P/OCF N/A
P/B 0.69
P/tB 0.76
EV/EBITDA 3.2
EPS(TTM)0.26
EY11.16%
EPS(NY)-0.17
Fwd EYN/A
FCF(TTM)-0.19
FCFYN/A
OCF(TTM)-0.08
OCFYN/A
SpS4.39
BVpS3.37
TBVpS3.08
PEG (NY)N/A
PEG (5Y)0.54
Graham Number4.44216 (90.65%)
Profitability
Industry RankSector Rank
ROA 2.65%
ROE 3.65%
ROCE 11.21%
ROIC 8.83%
ROICexc 10.88%
ROICexgc 12%
OM 9.9%
PM (TTM) 2.81%
GM 75.62%
FCFM N/A
ROA(3y)1.41%
ROA(5y)5.82%
ROE(3y)2.05%
ROE(5y)10.24%
ROIC(3y)5.16%
ROIC(5y)7.22%
ROICexc(3y)6.81%
ROICexc(5y)10.02%
ROICexgc(3y)7.75%
ROICexgc(5y)12.19%
ROCE(3y)6.54%
ROCE(5y)9.15%
ROICexgc growth 3Y14.91%
ROICexgc growth 5Y-14%
ROICexc growth 3Y18.93%
ROICexc growth 5Y-6.02%
OM growth 3Y26.04%
OM growth 5Y4.64%
PM growth 3Y1.07%
PM growth 5Y-6.94%
GM growth 3Y-0.48%
GM growth 5Y0.38%
F-Score2
Asset Turnover0.94
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA 0.17
Cap/Depr 76.1%
Cap/Sales 2.51%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.62
Quick Ratio 3.32
Altman-Z 2.9
F-Score2
WACC9.49%
ROIC/WACC0.93
Cap/Depr(3y)97.86%
Cap/Depr(5y)180.1%
Cap/Sales(3y)3.4%
Cap/Sales(5y)4.88%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)52.94%
EPS 3Y25.99%
EPS 5Y16.72%
EPS Q2Q%416.67%
EPS Next Y-166.69%
EPS Next 2Y-5.01%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)17.04%
Revenue growth 3Y7.76%
Revenue growth 5Y10.77%
Sales Q2Q%78.13%
Revenue Next Year-21.5%
Revenue Next 2Y-0.44%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y159.64%
EBIT growth 3Y35.82%
EBIT growth 5Y15.91%
EBIT Next Year-3.85%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-685.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-172.56%
OCF growth 3YN/A
OCF growth 5YN/A

ORGANOGENESIS HOLDINGS INC / ORGO Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ORGANOGENESIS HOLDINGS INC?

ChartMill assigns a fundamental rating of 5 / 10 to ORGO.


What is the valuation status of ORGANOGENESIS HOLDINGS INC (ORGO) stock?

ChartMill assigns a valuation rating of 4 / 10 to ORGANOGENESIS HOLDINGS INC (ORGO). This can be considered as Fairly Valued.


Can you provide the profitability details for ORGANOGENESIS HOLDINGS INC?

ORGANOGENESIS HOLDINGS INC (ORGO) has a profitability rating of 7 / 10.


Can you provide the financial health for ORGO stock?

The financial health rating of ORGANOGENESIS HOLDINGS INC (ORGO) is 4 / 10.


What is the earnings growth outlook for ORGANOGENESIS HOLDINGS INC?

The Earnings per Share (EPS) of ORGANOGENESIS HOLDINGS INC (ORGO) is expected to decline by -166.69% in the next year.